메뉴 건너뛰기




Volumn 5, Issue , 2011, Pages 157-164

Intranasal fentanyl for pain control: Current status with a focus on patient considerations

Author keywords

Breakthrough pain; Fentanyl; Intranasal; Pain

Indexed keywords

CODEINE; DICLOFENAC; DIPYRONE; FENTANYL CITRATE; MORPHINE; NARCOTIC ANALGESIC AGENT; PETHIDINE; PLACEBO; TRAMADOL;

EID: 84858263879     PISSN: None     EISSN: 1177889X     Source Type: Journal    
DOI: 10.2147/PPA.S7665     Document Type: Review
Times cited : (40)

References (36)
  • 1
    • 17844396756 scopus 로고    scopus 로고
    • Pain associated with advanced malignancy, including adjuvant analgesic drugs in cancer pain management
    • New York: Lippincott, Williams & Wilkins
    • Patt RB, Burton AW. Pain associated with advanced malignancy, including adjuvant analgesic drugs in cancer pain management. Evaluation and Treatment of Chronic Pain. New York: Lippincott, Williams & Wilkins; 1998:337-376.
    • (1998) Evaluation and Treatment of Chronic Pain , pp. 337-376
    • Patt, R.B.1    Burton, A.W.2
  • 2
    • 9244233833 scopus 로고    scopus 로고
    • Opioids in chronic non-cancer pain: Systematic review of efficacy and safety
    • Kalso E, Edwards JE, Moore RA, McQuay HJ. Opioids in chronic non-cancer pain: systematic review of efficacy and safety. Pain. 2004; 112:372-380.
    • (2004) Pain. , vol.112 , pp. 372-380
    • Kalso, E.1    Edwards, J.E.2    Moore, R.A.3    McQuay, H.J.4
  • 3
    • 33644982587 scopus 로고    scopus 로고
    • Steric interactions and the activity of fentanyl analogs at the [mu]-opioid receptor
    • Dosen-Micovic L, Ivanovic M, Micovic V. Steric interactions and the activity of fentanyl analogs at the [mu]-opioid receptor. Bioorg Med Chem. 2006;14:2887-2895.
    • (2006) Bioorg Med Chem. , vol.14 , pp. 2887-2895
    • Dosen-Micovic, L.1    Ivanovic, M.2    Micovic, V.3
  • 4
    • 38949134457 scopus 로고    scopus 로고
    • The clinical applications of intranasal opioids
    • Shelley K, Paech MJ. The clinical applications of intranasal opioids. Curr Drug Deliv. 2008;5:55.
    • (2008) Curr Drug Deliv. , vol.5 , pp. 55
    • Shelley, K.1    Paech, M.J.2
  • 6
    • 18444363020 scopus 로고    scopus 로고
    • Nasal administration of opioids for pain management in adults
    • Dale O, Hjortkjaer R, Kharasch ED. Nasal administration of opioids for pain management in adults. Acta Anaesthesiol Scand. 2002; 46:759-770.
    • (2002) Acta Anaesthesiol Scand. , vol.46 , pp. 759-770
    • Dale, O.1    Hjortkjaer, R.2    Kharasch, E.D.3
  • 7
    • 77249140012 scopus 로고    scopus 로고
    • Advantages of intranasal vaccination and considerations on device selection
    • Birkhoff M, Leitz M, Marx D. Advantages of intranasal vaccination and considerations on device selection. Indian J Pharm Sci. 2009;71:729.
    • (2009) Indian J Pharm Sci. , vol.71 , pp. 729
    • Birkhoff, M.1    Leitz, M.2    Marx, D.3
  • 8
    • 74549204827 scopus 로고    scopus 로고
    • A review of the clinical pharmacokinetics of opioids, benzodiazepines, and antimigraine drugs delivered intranasally
    • Veldhorst-Janssen NML, Fiddelers AAA, van der Kuy PHM, et al. A review of the clinical pharmacokinetics of opioids, benzodiazepines, and antimigraine drugs delivered intranasally. Clin Ther. 2009; 31:2954-2987.
    • (2009) Clin Ther. , vol.31 , pp. 2954-2987
    • Veldhorst-Janssen, N.M.L.1    Fiddelers, A.A.A.2    van der Kuy, P.H.M.3
  • 9
    • 0029968364 scopus 로고    scopus 로고
    • Patientenakzeptanz gegennber der patientenkontrollierten intranasalen Analgesie (PCINA)
    • Schwagmeier R, Oelmann T, Dannappel T, Striebel HW. Patientenakzeptanz gegennber der patientenkontrollierten intranasalen Analgesie (PCINA). Der Anaesthesist. 1996;45:231-234.
    • (1996) Der Anaesthesist. , vol.45 , pp. 231-234
    • Schwagmeier, R.1    Oelmann, T.2    Dannappel, T.3    Striebel, H.W.4
  • 10
    • 0023879968 scopus 로고
    • The influence of solution viscosity on nasal spray deposition and clearance
    • Pennington AK, Ratcliffe JH, Wilson CG, Hardy JG. The influence of solution viscosity on nasal spray deposition and clearance. Int J Pharm. 1988;43:221-224.
    • (1988) Int J Pharm. , vol.43 , pp. 221-224
    • Pennington, A.K.1    Ratcliffe, J.H.2    Wilson, C.G.3    Hardy, J.G.4
  • 11
    • 0023205098 scopus 로고
    • Bioadhesive microspheres as a potential nasal drug delivery system
    • Illum L, Jorgensen H, Bisgaard H, et al. Bioadhesive microspheres as a potential nasal drug delivery system. Int J Pharm. 1987;39:189-199.
    • (1987) Int J Pharm. , vol.39 , pp. 189-199
    • Illum, L.1    Jorgensen, H.2    Bisgaard, H.3
  • 12
    • 77955260161 scopus 로고    scopus 로고
    • Pharmacokinetics, analgesic effect, and tolerability of a single preprocedural dose of intranasal fentanyl in patients undergoing drain removal after breast reduction or augmentation surgery: A prospective, randomized, double-blind, placebo-controlled study
    • Veldhorst-Janssen NML, Fiddelers AAA, van der Kuy PHM, et al. Pharmacokinetics, analgesic effect, and tolerability of a single preprocedural dose of intranasal fentanyl in patients undergoing drain removal after breast reduction or augmentation surgery: a prospective, randomized, double-blind, placebo-controlled study. Clin Ther. 2010; 32:1427-1436.
    • (2010) Clin Ther. , vol.32 , pp. 1427-1436
    • Veldhorst-Janssen, N.M.L.1    Fiddelers, A.A.A.2    van der Kuy, P.H.M.3
  • 13
    • 0042242889 scopus 로고    scopus 로고
    • A new formulation of nasal fentanyl spray for postoperative analgesia: A pilot study
    • Paech MJ, Lim CB, Banks SL, et al. A new formulation of nasal fentanyl spray for postoperative analgesia: a pilot study. Anaesthesia. 2003;58:740-744.
    • (2003) Anaesthesia. , vol.58 , pp. 740-744
    • Paech, M.J.1    Lim, C.B.2    Banks, S.L.3
  • 14
    • 73349103141 scopus 로고    scopus 로고
    • Formulations of fentanyl for the management of pain
    • Grape S, Schug SA, Lauer S, Schug BS. Formulations of fentanyl for the management of pain. Drugs. 2010;70:57-72.
    • (2010) Drugs. , vol.70 , pp. 57-72
    • Grape, S.1    Schug, S.A.2    Lauer, S.3    Schug, B.S.4
  • 15
    • 77954886236 scopus 로고    scopus 로고
    • Intranasal fentanyl: From pharmacokinetics and bioavailability to current treatment applications
    • Panagiotou I, Mystakidou K. Intranasal fentanyl: from pharmacokinetics and bioavailability to current treatment applications. Expert Rev Anticancer Ther. 2010;10:1009-1021.
    • (2010) Expert Rev Anticancer Ther. , vol.10 , pp. 1009-1021
    • Panagiotou, I.1    Mystakidou, K.2
  • 16
    • 41649083735 scopus 로고    scopus 로고
    • Pharmacokinetics, efficacy, and tolerability of fentanyl following intranasal versus intravenous administration in adults undergoing third-molar extraction: A randomized, double-blind, double-dummy, two-way, crossover study
    • Christrup LL, Foster D, Popper LD, et al. Pharmacokinetics, efficacy, and tolerability of fentanyl following intranasal versus intravenous administration in adults undergoing third-molar extraction: a randomized, double-blind, double-dummy, two-way, crossover study. Clin Ther. 2008;30:469-481.
    • (2008) Clin Ther. , vol.30 , pp. 469-481
    • Christrup, L.L.1    Foster, D.2    Popper, L.D.3
  • 17
    • 76749095006 scopus 로고    scopus 로고
    • Pharmacokinetic comparisons of three nasal fentanyl formulations; pectin, chitosan and chitosanpoloxamer 188
    • Fisher A, Watling M, Smith A, Knight A. Pharmacokinetic comparisons of three nasal fentanyl formulations; pectin, chitosan and chitosanpoloxamer 188. Int J Clin Pharmacol Ther. 2010;48:138.
    • (2010) Int J Clin Pharmacol Ther. , vol.48 , pp. 138
    • Fisher, A.1    Watling, M.2    Smith, A.3    Knight, A.4
  • 18
    • 70350093401 scopus 로고    scopus 로고
    • The role of fentanyl in cancer-related pain
    • Prommer E. The role of fentanyl in cancer-related pain. J Palliat Med. 2009;12:947-954.
    • (2009) J Palliat Med. , vol.12 , pp. 947-954
    • Prommer, E.1
  • 19
    • 0025336568 scopus 로고
    • Breakthrough pain: Definition, prevalence and characteristics
    • Portenoy RK, Hagen NA. Breakthrough pain: definition, prevalence and characteristics. Pain. 1990;41:273-281.
    • (1990) Pain. , vol.41 , pp. 273-281
    • Portenoy, R.K.1    Hagen, N.A.2
  • 20
    • 0035059131 scopus 로고    scopus 로고
    • Breakthrough cancer pain: A randomized trial comparing oral transmucosal fentanyl citrate (OTFC) and morphine sulfate immediate release (MSIR)
    • Coluzzi PH, Schwartzberg L. Breakthrough cancer pain: a randomized trial comparing oral transmucosal fentanyl citrate (OTFC) and morphine sulfate immediate release (MSIR). Pain. 2001;91:123-130.
    • (2001) Pain. , vol.91 , pp. 123-130
    • Coluzzi, P.H.1    Schwartzberg, L.2
  • 21
    • 33750322229 scopus 로고    scopus 로고
    • A randomized, placebo-controlled study of fentanyl buccal tablet for breakthrough pain in opioid-treated patients with cancer
    • Portenoy RK, Taylor D, Messina J, Tremmel L. A randomized, placebo-controlled study of fentanyl buccal tablet for breakthrough pain in opioid-treated patients with cancer. Clin J Pain. 2006; 22:805.
    • (2006) Clin J Pain. , vol.22 , pp. 805
    • Portenoy, R.K.1    Taylor, D.2    Messina, J.3    Tremmel, L.4
  • 22
    • 68949120909 scopus 로고    scopus 로고
    • Efficacy and tolerability of intranasal fentanyl spray 50 to 200 [mu] g for breakthrough pain in patients with cancer: A phase III, multinational, randomized, doubleblind, placebo-controlled, crossover trial with a 10-month, open-label extension treatment period
    • Kress HG, Oronska A, Kaczmarek Z, et al. Efficacy and tolerability of intranasal fentanyl spray 50 to 200 [mu] g for breakthrough pain in patients with cancer: a phase III, multinational, randomized, doubleblind, placebo-controlled, crossover trial with a 10-month, open-label extension treatment period. Clin Ther. 2009;31:1177-1191.
    • (2009) Clin Ther. , vol.31 , pp. 1177-1191
    • Kress, H.G.1    Oronska, A.2    Kaczmarek, Z.3
  • 23
    • 77956098539 scopus 로고    scopus 로고
    • Fentanyl pectin nasal spray in breakthrough cancer pain
    • Taylor D, Galan V, Weinstein SM, et al. Fentanyl pectin nasal spray in breakthrough cancer pain. J Support Oncol. 2010;8:184.
    • (2010) J Support Oncol. , vol.8 , pp. 184
    • Taylor, D.1    Galan, V.2    Weinstein, S.M.3
  • 24
    • 78349255839 scopus 로고    scopus 로고
    • Long-term safety, tolerability, and consistency of effect of fentanyl pectin nasal spray for breakthrough cancer pain in opioid-tolerant patients
    • Portenoy RK, Raffaeli W, Torres LM, et al. Long-term safety, tolerability, and consistency of effect of fentanyl pectin nasal spray for breakthrough cancer pain in opioid-tolerant patients. J Opioid Manag. 2010;6:319.
    • (2010) J Opioid Manag. , vol.6 , pp. 319
    • Portenoy, R.K.1    Raffaeli, W.2    Torres, L.M.3
  • 25
    • 72549097280 scopus 로고    scopus 로고
    • A comparison of intranasal fentanyl spray with oral transmucosal fentanyl citrate for the treatment of breakthrough cancer pain: An open-label, randomised, crossover trial
    • Mercadante S, Radbruch L, Davies A, et al. A comparison of intranasal fentanyl spray with oral transmucosal fentanyl citrate for the treatment of breakthrough cancer pain: an open-label, randomised, crossover trial. Curr Med Res Opin. 2009;25:2805-2815.
    • (2009) Curr Med Res Opin. , vol.25 , pp. 2805-2815
    • Mercadante, S.1    Radbruch, L.2    Davies, A.3
  • 26
    • 0030029116 scopus 로고    scopus 로고
    • Patient-controlled intranasal analgesia (PCINA) for the management of postoperative pain: A pilot study
    • Striebel HW, Olmann T, Spies C, Brummer G. Patient-controlled intranasal analgesia (PCINA) for the management of postoperative pain: a pilot study. J Clin Anesth. 1996;8:4-8.
    • (1996) J Clin Anesth. , vol.8 , pp. 4-8
    • Striebel, H.W.1    Olmann, T.2    Spies, C.3    Brummer, G.4
  • 27
    • 0033759857 scopus 로고    scopus 로고
    • Patient-controlled intranasal analgesia: Effective alternative to intravenous PCA for postoperative pain relief
    • Toussaint S, Maidl J, Schwagmeier R, Striebel HW. Patient-controlled intranasal analgesia: effective alternative to intravenous PCA for postoperative pain relief. Can J Anaesth. 2000;47:299-302.
    • (2000) Can J Anaesth. , vol.47 , pp. 299-302
    • Toussaint, S.1    Maidl, J.2    Schwagmeier, R.3    Striebel, H.W.4
  • 28
    • 41649083735 scopus 로고    scopus 로고
    • Pharmacokinetics, efficacy, and tolerability of fentanyl following intranasal versus intravenous administration in adults undergoing third-molar extraction: A randomized, double-blind, double-dummy, two-way, crossover study
    • Christrup LL, Foster D, Popper LD, et al. Pharmacokinetics, efficacy, and tolerability of fentanyl following intranasal versus intravenous administration in adults undergoing third-molar extraction: a randomized, double-blind, double-dummy, two-way, crossover study. Clin Ther. 2008;30:469-481.
    • (2008) Clin Ther. , vol.30 , pp. 469-481
    • Christrup, L.L.1    Foster, D.2    Popper, L.D.3
  • 29
    • 77954828798 scopus 로고    scopus 로고
    • Effects of fentanyl administrated nasally and intravenously in post-operative analgesia in pediatric children: A comparative study of 36 cases
    • Cheng X, Li JH. Effects of fentanyl administrated nasally and intravenously in post-operative analgesia in pediatric children: a comparative study of 36 cases. Zhonghua Yi Xue Za Zhi. 2008;88:2898.
    • (2008) Zhonghua Yi Xue Za Zhi. , vol.88 , pp. 2898
    • Cheng, X.1    Li, J.H.2
  • 30
    • 0033636498 scopus 로고    scopus 로고
    • Use of intranasal fentanyl in children undergoing myringotomy and tube placement during halothane and sevoflurane anesthesia
    • Galinkin JL, Fazi LM, Cuy RM, et al. Use of intranasal fentanyl in children undergoing myringotomy and tube placement during halothane and sevoflurane anesthesia. Anesthesiology. 2000;93:1378.
    • (2000) Anesthesiology. , vol.93 , pp. 1378
    • Galinkin, J.L.1    Fazi, L.M.2    Cuy, R.M.3
  • 31
    • 0035035662 scopus 로고    scopus 로고
    • The effect of intranasal fentanyl on the emergence characteristics after sevoflurane anesthesia in children undergoing surgery for bilateral myringotomy tube placement
    • Finkel JC, Cohen IT, Hannallah RS, et al. The effect of intranasal fentanyl on the emergence characteristics after sevoflurane anesthesia in children undergoing surgery for bilateral myringotomy tube placement. Anaesth Analg. 2001;92:1164.
    • (2001) Anaesth Analg. , vol.92 , pp. 1164
    • Finkel, J.C.1    Cohen, I.T.2    Hannallah, R.S.3
  • 32
    • 55149115338 scopus 로고    scopus 로고
    • Postoperative pain relief in infants undergoing myringotomy and tube placement: Comparison of a novel regional anesthetic block to intranasal fentanylûa pilot analysis
    • Voronov P, Tobin MJ, Billings K, et al. Postoperative pain relief in infants undergoing myringotomy and tube placement: comparison of a novel regional anesthetic block to intranasal fentanylûa pilot analysis. Pediatric Anesthesia. 2008;18:1196-1201.
    • (2008) Pediatric Anesthesia. , vol.18 , pp. 1196-1201
    • Voronov, P.1    Tobin, M.J.2    Billings, K.3
  • 33
    • 33847239557 scopus 로고    scopus 로고
    • A randomized controlled trial comparing intranasal fentanyl to intravenous morphine for managing acute pain in children in the emergency department
    • Borland M, Jacobs I, King B, O'Brien D. A randomized controlled trial comparing intranasal fentanyl to intravenous morphine for managing acute pain in children in the emergency department. Ann Emerg Med. 2007;49:335-340.
    • (2007) Ann Emerg Med. , vol.49 , pp. 335-340
    • Borland, M.1    Jacobs, I.2    King, B.3    O'Brien, D.4
  • 34
    • 25844487516 scopus 로고    scopus 로고
    • Intranasal fentanyl is an equivalent analgesic to oral morphine in paediatric burns patients for dressing changes: A randomised double blind crossover study
    • Borland ML, Bergesio R, Pascoe EM, et al. Intranasal fentanyl is an equivalent analgesic to oral morphine in paediatric burns patients for dressing changes: a randomised double blind crossover study. Burns. 2005;31:831-837.
    • (2005) Burns. , vol.31 , pp. 831-837
    • Borland, M.L.1    Bergesio, R.2    Pascoe, E.M.3
  • 35
    • 0033835177 scopus 로고    scopus 로고
    • Prevalence and characteristics of breakthrough pain in cancer patients admitted to a hospice
    • Zeppetella G, O'Doherty CA, Collins S. Prevalence and characteristics of breakthrough pain in cancer patients admitted to a hospice. J Pain Symptom Manage. 2000;20:87-92.
    • (2000) J Pain Symptom Manage. , vol.20 , pp. 87-92
    • Zeppetella, G.1    O'Doherty, C.A.2    Collins, S.3
  • 36
    • 56949083592 scopus 로고    scopus 로고
    • Intranasal fentanyl for episodic breathlessness
    • Sitte T, Bausewein C. Intranasal fentanyl for episodic breathlessness. J Pain Symptom Manage. 2008;36:e3.
    • (2008) J Pain Symptom Manage. , vol.36
    • Sitte, T.1    Bausewein, C.2


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.